Serum antibody levels to glycosylphosphatidylinositols in specimens derived from matched Malian children with severe or uncomplicated Plasmodium falciparum malaria and healthy controls

American Journal of Tropical Medicine and Hygiene

Volumn 75, Issue 2, 2006, Pages 199-204

  Cissoko, Yacouba ^b   Daou, Modibo ^b   Lyke, Kirsten E ^a   Dicko, Alassane ^b   Diarra, Issa ^b   Kone, Abdoulaye ^b   Guindo, Ando ^b   Traore, Karim ^b   Krishnegowda, Gowdahalli ^c   Diallo, Dapa A ^b   Doumbo, Ogobara K ^b   Plowe, Christopher V ^a   Gowda, D Channe ^c   Sztein, Marcelo B ^a  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b UNIVERSITY OF BAMAKO   (Mali)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; PROTOZOON ANTIBODY;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCING CELL; ARTICLE; BRAIN MALARIA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA ANALYSIS; DISEASE SEVERITY; DISEASE TRANSMISSION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INFANT; INFECTION CONTROL; MALARIA FALCIPARUM; MALE; MALI; OUTCOME ASSESSMENT; PLASMODIUM FALCIPARUM; AGE; ANIMAL; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; IMMUNOLOGY; PRESCHOOL CHILD; SEASON; STATISTICAL MODEL;

MALIA; PLASMODIUM FALCIPARUM;

ADOLESCENT; AGE FACTORS; ANIMALS; ANTIBODIES, PROTOZOAN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GLYCOSYLPHOSPHATIDYLINOSITOLS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; LINEAR MODELS; MALARIA, FALCIPARUM; MALE; MALI; PLASMODIUM FALCIPARUM; SEASONS;

EID: 33748748296     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2006.75.199     Document Type: Article

References (22)

1. Kwiatkowski D, Hill AV, Sambou I, Twumasi P, Castracane J, Manogue KR, Cerami A, Brewster DR, Greenwood BM, 1990. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336: 1201-1204.
2. Kwiatkowski D, Molyneux ME, Stephens S, Curtis N, Klein N, Pointaire P, Smit M, Allan R, Brewster DR, Grau GE, 1993. Anti-TNF therapy inhibits fever in cerebral malaria. QJM 86: 91-98.
3. Lyke KE, Burges R, Cissoko Y, Sangare L, Dao M, Diarra I, Kone A, Harley R, Plowe CV, Doumbo OK, Sztein MB, 2004. Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect Immun 72: 5630-5637.
4. Schofield L, Hackett F, 1993. Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites. J Exp Med 177: 145-153.
5. Schofield L, Novakovic S, Gerold P, Schwarz RT, McConville MJ, Tachado SD, 1996. Glycosylphosphatidylinositol toxin of Plasmodium up-regulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction. J Immunol 156: 1886-1896.
6. Tachado SD, Gerold P, Schwarz R, Novakovic S, McConville M, Schofield L, 1997. Signal transduction in macrophages by glycosylphosphatidylinositols of Plasmodium, Trypanosoma, and Leishmania: activation of protein tyrosine kinases and protein kinase C by inositolglycan and diacylglycerol moieties. Proc Natl Acad Sci USA 94: 4022-4027.
7. Gerold P, Dieckmann-Schuppert A, Schwarz RT, 1994. Glycosylphosphatidylinositols synthesized by asexual erythrocytic stages of the malarial parasite, Plasmodium falciparum. Candidates for plasmodial glycosylphosphatidylinositol membrane anchor precursors and pathogenicity factors. J Biol Chem 269: 2597-2606.
8. Zhu J, Krishnegowda G, Gowda DC, 2005. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: the requirement of extracellular signal-regulated kinase, p38, c-Jun N-terminal kinase and NF-kappaB pathways for the expression of proinflammatory cytokines and nitric oxide. J Biol Chem 280: 8617-8627.
9. Krishnegowda G, Hajjar AM, Zhu J, Douglass EJ, Uematsu S, Akira S, Woods AS, Gowda DC, 2005. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J Biol Chem 280: 8606-8616.
10. Naik RS, Branch OH, Woods AS, Vijaykumar M, Perkins DJ, Nahlen BL, Lai AA, Cotter RJ, Costello CE, Ockenhouse CF, Davidson EA, Gowda DC, 2000. Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. J Exp Med 192: 1563-1576.
11. Schofield L, Hewitt MC, Evans K, Siomos MA, Seeberger PH, 2002. Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Nature 418: 785-789.
12. De Souza JB, Todd J, Krishegowda G, Gowda DC, Kwiatkowski D, Riley EM, 2002. Prevalence and boosting of antibodies to Plasmodium falciparum glycosylphosphatidylinositols and evaluation of their association with protection from mild and severe clinical malaria. Infect Immun 70: 5045-5051.
13. Perraut R, Diatta B, Marrama L, Garraud O, Jambou R, Long-acre S, Krishnegowda G, Dieye A, Gowda DC, 2005. Differential antibody responses to Plasmodium falciparum glycosylphosphatidylinositol anchors in patients with cerebral and mild malaria. Microbes Infect 7: 682-687.
14. Boutlis CS, Fagan PK, Gowda DC, Lagog M, Mgone CS, Bockarie MJ, Anstey NM, 2003. Immunoglobulin G (IgG) responses to Plasmodium falciparum glycosylphosphatidylinositols are short-lived and predominantly of the IgG3 subclass. J Infect Dis 187: 862-865.
15. Lyke KE, Dicko A, Kone A, Coulibaly D, Guindo A, Cissoko Y, Traore K, Plowe CV, Doumbo OK, 2004. Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali. Vaccine 22: 3169-3174.
16. Lyke KE, Dicko A, Dabo A, Sangare L, Kone A, Coulibaly D, Guindo A, Traore K, Daou M, Diarra I, Sztein MB, Plowe CV, Duombo OK, 2005. Association of Schistosoma haematobium infection with protection against acute Plasmodium falciparum malaria in Malian children. Am J Trop Med Hyg 73: 1124-1130.
17. Coulibaly D, Diallo DA, Thera MA, Dicko A, Guindo AB, Kone AK, Cissoko Y, Coulibaly S, Djimde A, Lyke K, Doumbo OK, Plowe CV, 2002. Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali. Am J Trop Med Hyg 67: 604-610.
18. 2000. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 94 (Suppl 1): S1-S90.
19. Diallo DA, Doumbo OK, Plowe CV, Wellems TE, Emanuel EJ, Hurst SA, 2005. Community permission for medical research in developing countries. Clin Infect Dis 41: 255-259.
20. Hardy MR, Townsend RR, 1994. High-pH anion-exchange chromatography of glycoprotein-derived carbohydrates. Methods Enzymol 230: 208-225.
21. Hudson Keenihan SN, Ratiwayanto S, Soebianto S, Krisin, Marwoto H, Krishnegowda G, Gowda DC, Bangs MJ, Fryauff DJ, Richie TL, Kumar S, Baird JK, 2003. Age-dependent impairment of IgG responses to glycosylphosphatidylinositol with equal exposure to Plasmodium falciparum among Javanese migrants to Papua, Indonesia. Am J Trop Med Hyg 69: 36-41.
22. Boutlis CS, Gowda DC, Naik RS, Maguire GP, Mgone CS, Bockarie MJ, Lagog M, Ibam E, Lorry K, Anstey NM, 2002. Antibodies to Plasmodium falciparum glycosylphosphatidylinositols: inverse association with tolerance of parasitemia in Papua New Guinean children and adults. Infect Immun 70: 5052-5057.